FlexAbility SE
Device
Abbott Laboratories
Total Payments
$1.4M
Transactions
194
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $1.4M | 194 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.4M | 194 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT | Abbott Laboratories | $1.0M | 0 |
| Flexability Sensor Enabled Substrate Targeted Ablation for the Reduction of VT (Less-VT) | Abbott Laboratories | $220,000 | 0 |
| LESS-VT | Abbott Laboratories | $93,000 | 0 |
| FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study (LESS-VT) | Abbott Laboratories | $27,240 | 0 |
Top Doctors Receiving Payments for FlexAbility SE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Arvada, CO | $1.4M | 194 |
Ad
Manufacturing Companies
- Abbott Laboratories $1.4M
Product Information
- Type Device
- Total Payments $1.4M
- Total Doctors 0
- Transactions 194
About FlexAbility SE
FlexAbility SE is a device associated with $1.4M in payments to 0 healthcare providers, recorded across 194 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2019. In 2019, $1.4M was paid across 194 transactions to 0 doctors.
The most common payment nature for FlexAbility SE is "Unspecified" ($1.4M, 100.0% of total).
FlexAbility SE is associated with 4 research studies, including "FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT" ($1.0M).